GESTIÓN EN SALUD PÚBLICA: julio 2022

Annual Conference The NSGC Annual Conference showcases advancements across the breadth of the genetic counseling profession to provide education and build community. Attendees will gain knowledge of clinical and scientific best practices and insights into emerging research. The conference provides a unique opportunity to engage and network with colleagues and pursue professional development.

Home - RNA at the Bench and Bedside III

2022 Annual Meeting - ASHG

Specific PHGKB|Pharmacogenomics PHGKB|PHGKB

Specific PHGKB|Health Equity PHGKB|PHGKB

Specific PHGKB|Environmental Health PHGKB|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Re-envisioning Community Genetics: Community Empowerment in Preventive Genomics H Wand et al, Research Square, July 19, 2022

Main|Search|PHGKB

Approaches to Ethical Deliberation in Precision Public Health | CDC

Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus J Isidro et al, Nature Medicine, June 25, 2022

Main|Search|PHGKB

What is Epigenetics? | CDC

Fulfilling the Promise of Epigenetics Requires More Studies in Diverse Populations | Blogs | CDC

sábado, 23 de julio de 2022

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents | Effective Health Care (EHC) Program

Radiation Therapy for Bone Metastases | Effective Health Care (EHC) Program

Cervical Degenerative Disease Treatment | Effective Health Care (EHC) Program

Behavioral Interventions for Migraine Prevention (BIMP) | Effective Health Care (EHC) Program

Use of Telehealth During the COVID-19 Era | Effective Health Care (EHC) Program

DERECHO Y SALUD: LEY NACIONAL DE RESPUESTA INTEGRAL AL VIH, HEPATITIS VIRALES, OTRAS INFECCIONES DE TRANSMISIÓN SEXUAL-ITS- Y TUBERCULOSIS-TBC-

DERECHO Y SALUD: CREACIÓN DEL RÉGIMEN DE PROTECCIÓN INTEGRAL DEL NIÑO, NIÑA Y ADOLESCENTE CON CÁNCER

DERECHO Y SALUD: SE AMPLIAN LAS PRESTACIONES DEL PMO PARA EL TRATAMIENTO DE LAS PERSONAS CON OBESIDAD

DERECHO Y SALUD: LEY DE CUIDADOS PALIATIVOS

DERECHO Y SALUD: FALLO: LA ENTIDAD DE MEDICINA PREPAGA NO DEBE CUBRIR EL ESTUDIO GENÉTICO PREIMPLANTACIONAL POR NO ESTAR PREVISTO EN LAS NORMAS DE ACCESO A LOS TRATAMIENTOS DE REPRODUCCIÓN MÉDICAMENTE ASISTIDA

DERECHO Y SALUD: FALLO: LA ENTIDAD DE MEDICINA PREPAGA NO DEBE CUBRIR EL ESTUDIO GENÉTICO PREIMPLANTACIONAL POR NO ESTAR PREVISTO EN LAS NORMAS DE ACCESO A LOS TRATAMIENTOS DE REPRODUCCIÓN MÉDICAMENTE ASISTIDA

DERECHO Y SALUD: COMENTARIO A FALLO POR DISCRIMINACIÓN LABORAL POR SER VIH POSITIVO

The Patient Perspective: Government price-setting harms patients

Failure to Respond to an ANDA Complete Response Letter Within the Regulatory Timeframe Guidance for Industry | FDA

Orange Book Questions and Answers Guidance for Industry | FDA

IDEA Pharma: Pharmaceutical Invention & Innovation Index 2021 | Fortune

Director's Blog: the latest from USPTO leadership

xcenda_biosimilar_trends_issue_one_july2022.pdf

Patent policy changes proposed by USPTO and FDA would leave patients behind

Federal Register :: Revising the National Drug Code Format and Drug Label Barcode Requirements

What’s New for Biologics | FDA

FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health | FDA

viernes, 22 de julio de 2022

Consumer Price Index - June 2022

Survey Says: Prescription drug prices are not fueling inflation concerns for Americans

House OKs Bill to Protect Contraception From Supreme Court

FDA Details Optimized Approach for Regulatory Oversight Tools to Better Protect Public Health | FDA

U.S. Transition to 988 Suicide & Crisis Lifeline Begins Saturday | SAMHSA

DTAC Bulletin: First Responders and Disaster Behavioral Health

Core Resource on Alcohol | National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Advisory: Peer Support Services in Crisis Care | SAMHSA Publications and Digital Products

Helping Girls and Young Women Stay Healthy by Avoiding Alcohol | SAMHSA Publications and Digital Products

Healing Roots: Cultural Competence and Community Inclusion | Mental Health Technology Transfer Center (MHTTC) Network

A Cultural Adaptation of Screening, Brief Intervention, and Referral to Treatment, (SBIRT) for Working with Hispanic and Latinx Communities - Part 1 | Addiction Technology Transfer Center (ATTC) Network

A Cultural Adaptation of Screening, Brief Intervention, and Referral to Treatment, (SBIRT) for Working with Hispanic and Latinx Communities - Part 1 | Addiction Technology Transfer Center (ATTC) Network

WFD Series 2: Principles of the Environmental Approach for the Prevention Professional | Prevention Technology Transfer Center (PTTC) Network

Mindful Monday Session 10 | Mental Health Technology Transfer Center (MHTTC) Network

Substance Use Disorders: Explained and Treated Through Attachment Theory | Mental Health Technology Transfer Center (MHTTC) Network

Timely Treatment for Patients Experiencing Serious Mental Illness and Anosognosia—Webinar Friday, July 29, 2022 11:30 AM ET

Inscripción a la reunión - Zoom

Native Food is Medicine: Providing Emotional/ Resilient Support for AI/AN Youth through the Healing Power of Food - Part 4 | Mental Health Technology Transfer Center (MHTTC) Network

It's Just Tech ... An Interactive Tech Training for Providers and Caretakers Working with the IDD Community - Session 2 | Mental Health Technology Transfer Center (MHTTC) Network

CLAS Series Part 4: The Complexities of Healthcare and Wellness for Men Who Have Sex with Men | Addiction Technology Transfer Center (ATTC) Network

Recruitment & Retention Series: Part I: Behavioral Health Workforce Support: Current State and Future Opportunities | Addiction Technology Transfer Center (ATTC) Network

July 26-28: Innovations in Recovery Leadership

Opioid Response Network

Involving Families to Improve MOUD Adherence - PCSS

Reclaiming Native Psychological Brilliance - Substance Use and Hungry Ghosts | Mental Health Technology Transfer Center (MHTTC) Network

Self-Care & Wellness for ALL (7/25/22) | Addiction Technology Transfer Center (ATTC) Network

FDA’s Ongoing Use of Inspectional Tools for Ensuring Access to Safe, Quality Food and Medical Products During the COVID-19 Pandemic | FDA

Biomarkers and surrogate endpoints are critical tools for drug development

PhRMA member companies’ R&D investments reach record high of $102.3 billion in 2021

Compounding Quality Center of Excellence Annual Conference - 09/06/2022 | FDA

UPDATE: Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures: FDA Safety Communication | FDA

Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation - 07/27/2022 | FDA

FDA Workshop: Increasing the Efficiency of Biosimilar Development Programs - 09/19/2022 | FDA

FDA to Hold Public Workshop to Discuss Biosimilar Product Development

Inscripción al seminario web - Zoom

What’s New for Biologics | FDA

CDRHNew - News and Updates | FDA

CDER Conversation: CDER’s Drug Quality Sampling and Testing program | FDA

Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--“Dose Banding” | FDA

Unique Device Identification: Policy Regarding Compliance Dates for Class I and Unclassified Devices, Direct Marking, and Global Unique Device Identification Database Requirements for Certain Devices | FDA

jueves, 21 de julio de 2022

New Device Design Brings Unparalleled Confidence to Cell Measurements | NIST

NIST Updates Guidance for Health Care Cybersecurity | NIST

The CAHPS Home and Community Based Services Survey Data Submission Login | The CAHPS® Database

CDER Conversation: CDER’s Drug Quality Sampling and Testing program | FDA

Abortion Laws Deny Treatments Needed for Autoimmune Disease

Racial Disparities?; Long COVID Clues; Fixing Drug Costs, ACA

A Look at Company Efforts to Enhance Clinical Trial Diversity | PhRMA

Clinical Trial Diversity

Why the US is ill prepared if monkeypox escalates into a pandemic - Genetic Literacy Project

Israeli hospital to test Moderna vaccine against Omicron - ISRAEL21c

A surgical headset born on a fighter jet - ISRAEL21c

A universal antiviral drug is being developed in Jerusalem - ISRAEL21c

The 2022 NIST-Hosted Workshop on Standards for Microbiome and Multi'Omics Measurements | NIST

Medication Safety Events Related to Diagnostic Imaging | PSNet

Preventable Transfer to the Hospital | PSNet

Missing a Large Vessel Occlusion Stroke in a Patient with a History of Seizures. | PSNet

Assessment of changes in visits and antibiotic prescribing during the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 Pandemic. | PSNet

Medication-related medical emergency team activations: a case review study of frequency and preventability. | PSNet

Implementing root cause analysis and action: integrating human factors to create strong interventions and reduce risk of patient harm. | PSNet

Is monkeypox a global public-health emergency?

Hard-won reproductive health rights could be threatened by US Supreme Court decision on abortion

CDRHNew - News and Updates | FDA

Is FDA Going to Get A Little Help From Its Friends at the PTO?

Evaluation of Therapeutic Equivalence | FDA

REGISTER NOW! NIH Data Management and Sharing Policy Webinar Series | Data Sharing

Do Not Use Ultraviolet (UV) Wands That Give Off Unsafe Levels of Radiation: FDA Safety Communication | FDA

NIAID Funding News, July 20, 2022

Funding News

Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--“Dose Banding” | FDA

miércoles, 20 de julio de 2022

Use of Telehealth During the COVID-19 Era | Effective Health Care (EHC) Program

Cognitive and implicit biases in nurses' judgment and decision-making: a scoping review. | PSNet

Long-term risk of overdose or mental health crisis after opioid dose tapering. | PSNet

Analysis of variation between diagnosis at admission vs discharge and clinical outcomes among adults with possible bacteremia. | PSNet

Medical Expenditure Panel Survey Home

Opioid Use Among Elderly & Non-Elderly Adults by Socioeconomic Characteristics | Agency for Healthcare Research and Quality

AHRQ Grantee Profiles | Agency for Healthcare Research and Quality

Enhancing Healthcare Quality for Hospitalized Children | Agency for Healthcare Research and Quality

Temporal Trends in Antimicrobial Prescribing During Hospitalization for Potential Infection and Sepsis - PubMed

Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis - PubMed

Accelerating Surgical Site Infection Abstraction With a Semi-automated Machine-learning Approach - PubMed

Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative - PubMed

Health Care Use and Outcomes in Assisted Living Communities: Race, Ethnicity, and Dual Eligibility - PubMed

AHRQ Webinar for Measure Dx Hora 1 ago 2022 04:00 p. m. en Hora del este (EE. UU. y Canadá)

Inscripción a la reunión - Zoom

Measure Dx: A Resource To Identify, Analyze, and Learn From Diagnostic Safety Events | Agency for Healthcare Research and Quality

Association of Race, Ethnicity, and Rurality With Major Leg Amputation or Death Among Medicare Beneficiaries Hospitalized With Diabetic Foot Ulcers - PubMed

Expected Payers and Patient Characteristics of Maternal Emergency Department Care, 2019

Development and Validation of the Trust in My Doctor, Trust in Doctors in General, and Trust in the Health Care Team Scales - PubMed

Usability and Accessibility of Publicly Available Patient Safety Databases - PubMed

Dashboard Design to Identify and Balance Competing Risk of Multiple Hospital-Acquired Conditions - PubMed

Dra. Marisa Aizenberg: Salud a golpe de clic con la cercanía del médico de cabecera

PETA Petition to FSIS to Remove Animal Raising Claims from Label Approval Process

Evaluation of Therapeutic Equivalence | FDA

CDRHNew - News and Updates | FDA

FDA Workshop: Increasing the Efficiency of Biosimilar Development Programs - 09/19/2022 | FDA

Inscripción al seminario web - Zoom

martes, 19 de julio de 2022

New research shows competition driven by biosimilars helps control costs in Part B

Influence of chr12q24.13 domain on COVID-19 severity

Fauci to Retire by End of Biden's First Term

COVID Childcare Woes Increased Stress in Medical Workers: Study

Canadian Emergency Doctors Urge Solution of Staffing Crisis

Data Exchange; Discounted Pharmacy; and Healthcare Antitrust Push

Cardiovascular-related deaths in the U.S. fall, but disparities remain | National Institutes of Health (NIH)

CDRHNew - News and Updates | FDA

FDA authorizes Novavax Covid-19 vaccine - STAT

COVID-19 Noticias / Opiniones CHEQUEADAS EN INGLÉS y otros idiomas

UK weekly COVID-19 infections rise, booster jab programme announced | Reuters

New coronavirus mutant raises concerns in India and beyond | AP News

COVID-19 Informes Científicos CHEQUEADOS COMPLETOS REVISADOS (full texts)

Indice General de Autoevaluaciones

Novedades COVID-19

COVID-19 ESPECIALISTAS opinan Expertos Invitados (Castellano)

COVID-19 Noticias / Opiniones CHEQUEADAS

Dra. Marisa Aizenberg: Brecha digital y demoras en la atención teléfonica, puntos a mejorar de la telemedicina

Tainted Sexual Enhancement Products | FDA

What’s New for Biologics | FDA

lunes, 18 de julio de 2022

Major Study Finds Significant National Patient Safety Improvement | Agency for Healthcare Research and Quality

How do different COVID-19 recovery paths impact health, food systems, and the environment?

The state of antimicrobial resistance in the United States immediately following the 2020 peaks of the COVID-19 pandemic

Biden’s FTC has blocked 4 hospital mergers and is poised to thwart more consolidation attempts

Conservative blocs unleash litigation to curb public health powers

FTC official: Antitrust push in health care must focus on a merger’s ‘human impact’

lp-2-ifgr-horz - robust R&D ecosystem

lp-2-ifgr-horz

ICYMI: New approvals by the FDA in 2021 offer greater treatment options for patients

Summary of NDA Approvals & Receipts, 1938 to the present | FDA

Medicines in Development for Blood Disorders 2022 Report | PhRMA

2022 PhRMA Annual Membership Survey | PhRMA

PhRMA member companies’ R&D investments reach record high of $102.3 billion in 2021

White House Office of Science & Technology Policy Virtual Conversation: How Science Has Offered Hope for Treatment-Resistant Depression

Inscripción al seminario web - Zoom

CMS Proposes Rule to Implement Mandatory Medicare Part B Discarded Drug Rebates

Instructions for Use — Patient Labeling for Human Prescription Drug and Biological Products — Content and Format | FDA

CDRHNew - News and Updates | FDA

domingo, 17 de julio de 2022

Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections. Serpa Paula Hayakawa et al. Genome medicine 2022 7 (1) 74

Main|Search|PHGKB

Monkeypox outbreak in Madrid (Spain): clinical and virological aspects. Orviz Eva et al. The Journal of infection 2022 7

Main|Search|PHGKB

Specific PHGKB|Pharmacogenomics PHGKB|PHGKB

Specific PHGKB|Health Equity PHGKB|PHGKB

Specific PHGKB|Environmental Health PHGKB|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

From All of Us Research to All of Us in the Real World: Using the All of Us Research Program Data to Improve Population Health | CDC

The Routine Failure to Clinically Identify Monogenic Cases of Common Disease in Clinical Practice: Addressing Diagnostic Misattributions and Errors | CDC

Approaches to Ethical Deliberation in Precision Public Health | CDC

COVID-19 GPH|Home|PHGKB

COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response | BMC Infectious Diseases | Full Text

Precision Health Innovations in the Pandemic Era | Blogs | CDC

CDC Warns About Potentially Deadly Virus in Infants

Violent Patient Throws Scalding Oil on MD; Other Patient Dangers

DoD Program Aims to Build a Pharmacy in (Not on) the Body

DERECHO Y SALUD: BUENAS PRÁCTICAS EN TELECONSULTAS

DERECHO Y SALUD: LA ENTIDAD DE MEDICINA PREPAGA DEBE CUBRIR LA PRESTACIÓN DE ACOMPAÑANTE TERAPÉUTICO PRESCRIPTA, PARA MENOR CON TRASTORNO DEL ESPECTRO AUTISTA

DERECHO Y SALUD: Aire de Justicia: Medicamentos de alto precio. Medicamentos de terapia g...

sábado, 16 de julio de 2022

International Journal for Equity in Health | Home page

International Journal of Behavioral Nutrition and Physical Activity | Home page

International Journal of Mental Health Systems | Home page

Israel Journal of Health Policy Research | Home page

Journal of Pharmaceutical Policy and Practice | Home page

’Health is Wealth’ focus for global healthcare trade and export summit at Birmingham 2022

Study assesses the acceptance of Medicaid insurance among patients diagnosed with cancers

Scientists combine robotics with biology to construct biohybrid microrobots

Research tests the effectiveness of a callback program on preventing ER return visits

Strategies for managing patients with psychiatric illness in the reopening period of the COVID-19 pandemic in China - The Lancet Psychiatry

Why we still need a pandemic treaty - The Lancet Global Health

Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption - The Lancet

We need to make sure telecommuting does not exacerbate gender disparity - The Lancet

Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA - The Lancet

Accelerating pooled licensing of medicines to enhance global production and equitable access - The Lancet

Leaders from Top Universities and the Biopharmaceutical Research Industry to Host Virtual Press Briefing Launching New Community-Based Initiative to Enhance Clinical Trial Diversity

Inscripción al seminario web - Zoom

Dra. Marisa Aizenberg: "La telemonitorización disminuye el uso de recursos sanitarios"

What’s New for Biologics | FDA

For Monkeypox Testing, Use Lesion Swab Samples to Avoid False Results: FDA Safety Communication | FDA

viernes, 15 de julio de 2022

What role did local governments have in responding to the COVID-19 pandemic?

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

California’s public health tax is dead for the year

’Health is Wealth’ focus for global healthcare trade and export summit at Birmingham 2022

Study: Prescribing rate of non-opioid pain medications increased after 2016 CDC guideline

PhRMA Statement on the TRIPS Waiver Agreement | PhRMA

Intellectual Property waiver on COVID-19 innovation is unnecessary and harmful

ICYMI: PhRMA’s Ubl pens op-ed on IP waiver for COVID-19 technologies

National Advisory Council (NAC) Meeting | Agency for Healthcare Research and Quality

FDA approves crizotinib for ALK-positive inflammatory myofibroblastic tumor | FDA

Instructions for Use — Patient Labeling for Human Prescription Drug and Biological Products — Content and Format | FDA

Final Research Plan: Breastfeeding: Interventions | United States Preventive Services Taskforce

Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US

Tell Congress: Patients Deserve Better

Tell Congress: Patients Deserve Better Tell Washington: Protect Access to New Medicines Víctor Norberto, Some in Congress are proposing legislation that would give the federal government unprecedented, sweeping authority to set prices for medicines. While some would have you believe this is “negotiation,” it isn’t. They essentially just want the government to dictate medicine prices. Arbitrary government price setting will decimate the innovative ecosystem in the United States that has brought hope to so many Americans in the form of new medical advances where before there were none. No matter what they call it, the latest drug pricing plan in the reconciliation package will result in the same outcome: negative consequences for patients. Stand Up for Patient Access ▸ Why does this matter to you? Because government price setting could mean fewer new medicines in the coming years. Nearly 1/5 of research and development investment could be lost by 2039 if these price setting proposals are implemented. Will your health or a loved one's be impacted? What can be done? Given your interest in a strong American innovation ecosystem, we’re asking you to let Congress know that patients deserve better. They must reject proposals that jeopardize lifesaving treatments and cures and work on real solutions to make sure patients can afford their medicines at the pharmacy counter. The latest drug pricing plan is a detriment to patients and the future of medical research. This alert is to let you know this proposal is being considered. As a subscriber to the PhRMA Innovation newsletter, now is your chance to voice your concerns about the impact it would have on you, your family and patients throughout the country. Tell Congress that patients deserve better!